ELIZABETH CHERRY SQUIERS
Medical Practice in Princeton By The Sea, CA
License number
Pennsylvania MD041996L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Princeton By The Sea, CA 94019
Pennsylvania
Pennsylvania
Personal information
See more information about ELIZABETH CHERRY SQUIERS at radaris.comName
Address
Phone
229 Myrtle St, Half Moon Bay, CA 94019
229 Myrtle St, Half Moon Bay, CA 94019
Professional information
Dr. Elizabeth Squiers, Half Moon Bay CA - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
229 Myrtle St, Half Moon Bay 94019
(650) 726-6618 (Phone), (650) 726-6602 (Fax)
(650) 726-6618 (Phone), (650) 726-6602 (Fax)
Certifications:
General Surgery, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Thomas Jefferson University
Graduated: 1983
Beaumont Hospital-Royal Oak Campus
Shands Hospital At The University Of Florida
Thomas Jefferson University
Graduated: 1983
Beaumont Hospital-Royal Oak Campus
Shands Hospital At The University Of Florida
Modulation Of Hsp47 Expression
US Patent:
2011017, Jul 21, 2011
Filed:
Dec 8, 2010
Appl. No.:
12/963600
Inventors:
Xiaomei Jin - Oceanside CA, US
Lei Yu - Oceanside CA, US
Hirokazu Takahashi - Sapporo, JP
Yasunobu Tanaka - Sapporo, JP
Yoshiro Niitsu - Sapporo, JP
Elena Feinstein - Rehovot, IL
Sharon Avkin-Nachum - Nes Ziona, IL
Hagar Kalinski - Rishon Le-Zion, IL
Igor Mett - Rehovot, IL
Shai Erlich - Belmont CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Lei Yu - Oceanside CA, US
Hirokazu Takahashi - Sapporo, JP
Yasunobu Tanaka - Sapporo, JP
Yoshiro Niitsu - Sapporo, JP
Elena Feinstein - Rehovot, IL
Sharon Avkin-Nachum - Nes Ziona, IL
Hagar Kalinski - Rishon Le-Zion, IL
Igor Mett - Rehovot, IL
Shai Erlich - Belmont CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
International Classification:
A61K 31/713, C07H 21/02, A61P 43/00, C07H 21/00
US Classification:
514 44 A, 536 245
Abstract:
Provided herein are compositions, methods and kits for modulating expression of target genes, particularly heat shock protein 47 (hsp47). The compositions, methods and kits may include nucleic acid molecules (for example, short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA) or short hairpin RNA (shRNA)) that modulate a gene encoding hsp47, for example, the gene encoding human hsp47. The composition and methods disclosed herein may also be used in treating conditions and disorders associated with hsp47 such as liver fibrosis, pulmonary fibrosis, peritoneal fibrosis and kidney fibrosis.
Genotype Specific Methods For Treating Human Subjects Using 4-Methylpyrazole
US Patent:
2012025, Oct 4, 2012
Filed:
Jun 9, 2010
Appl. No.:
13/376933
Inventors:
Thomas E. Daley - San Mateo CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
International Classification:
A61K 31/415, A61P 25/28, A61P 25/00, A61P 9/10, A61P 25/16, A61P 35/00, A61P 9/12
US Classification:
514406
Abstract:
Provided herein are methods of administering 4-methylpyrazole (4-MP), or physiologically acceptable salts thereof, to subjects of genetic subpopulations expressing specific polymorphisms of the alcohol dehydrogenase and aldehyde dehydrogenase genes. Also provided herein are methods to prevent or ameliorate ethanol intolerance, reduce or ameliorate symptoms associated with acetaldehyde accumulation accompanying ethanol consumption, or reduce the risk of diseases or disorders caused by consumption of ethanol, comprising administering 4-MP, or physiologically acceptable salts thereof, to subjects of these subpopulations.
Genotype Specific Methods For Treating Human Subjects Using 4-Methylpyrazole
US Patent:
2012032, Dec 20, 2012
Filed:
Jun 21, 2012
Appl. No.:
13/529695
Inventors:
Thomas E. Daley - San Mateo CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
Assignee:
RAPTOR THERAPEUTICS INC. - Novato CA
International Classification:
A61K 31/415, A61P 1/12, A61P 1/08
US Classification:
514406
Abstract:
Provided herein are methods of administering 4-methylpyrazole (4-MP), or physiologically acceptable salts thereof, to subjects of genetic subpopulations expressing specific polymorphisms of the alcohol dehydrogenase and aldehyde dehydrogenase genes. Also provided herein are methods to prevent or ameliorate ethanol intolerance, reduce or ameliorate symptoms associated with acetaldehyde accumulation accompanying ethanol consumption, or reduce the risk of diseases or disorders caused by consumption of ethanol, comprising administering 4-MP, or physiologically acceptable salts thereof, to subjects of these subpopulations.
4-Methylpyrazole Formulations For Inhibiting Ethanol Intolerance
US Patent:
2013015, Jun 13, 2013
Filed:
Feb 1, 2013
Appl. No.:
13/757329
Inventors:
Raptor Therapeutiacs Inc. - Novato CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
Assignee:
Raptor Therapeutiacs Inc. - Novato CA
International Classification:
A61K 31/415
US Classification:
514406
Abstract:
Provided herein are methods, compositions and formulations to prevent or ameliorate ethanol intolerance, reduce or ameliorate symptoms associated with acetaldehyde accumulation accompanying ethanol consumption, or reduce the risk of diseases or disorders caused by acetaldehyde accumulation, comprising administering 4-MP, or physiologically acceptable salts thereof, to subjects with reduced or absent aldehyde dehydrogenase subtype 2 (ALDH2) activity.
4-Methylpyrazole Formulations For Inhibiting Ethanol Intolerance
US Patent:
2011005, Mar 3, 2011
Filed:
Jun 9, 2010
Appl. No.:
12/797594
Inventors:
Thomas E. Daley - San Mateo CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
Elizabeth C. Squiers - Half Moon Bay CA, US
Kin-Hung Peony Yu - Hillsborough CA, US
International Classification:
A61K 31/415, A61P 39/00, A61P 1/00, A61P 35/00, A61P 25/28, A61P 9/12, A61P 25/16
US Classification:
514406
Abstract:
Provided herein are methods, compositions and formulations to prevent or ameliorate ethanol intolerance, reduce or ameliorate symptoms associated with acetaldehyde accumulation accompanying ethanol consumption, or reduce the risk of diseases or disorders caused by acetaldehyde accumulation, comprising administering 4-MP, or physiologically acceptable salts thereof, to subjects with reduced or absent aldehyde dehydrogenase subtype 2 (ALDH2) activity.